BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 12672248)

  • 1. Kinase inhibitors: not just for kinases anymore.
    McGovern SL; Shoichet BK
    J Med Chem; 2003 Apr; 46(8):1478-83. PubMed ID: 12672248
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification and prediction of promiscuous aggregating inhibitors among known drugs.
    Seidler J; McGovern SL; Doman TN; Shoichet BK
    J Med Chem; 2003 Oct; 46(21):4477-86. PubMed ID: 14521410
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A common mechanism underlying promiscuous inhibitors from virtual and high-throughput screening.
    McGovern SL; Caselli E; Grigorieff N; Shoichet BK
    J Med Chem; 2002 Apr; 45(8):1712-22. PubMed ID: 11931626
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A specific mechanism of nonspecific inhibition.
    McGovern SL; Helfand BT; Feng B; Shoichet BK
    J Med Chem; 2003 Sep; 46(20):4265-72. PubMed ID: 13678405
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Screening in a spirit haunted world.
    Shoichet BK
    Drug Discov Today; 2006 Jul; 11(13-14):607-15. PubMed ID: 16793529
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Colloidal aggregation and the in vitro activity of traditional Chinese medicines.
    Duan D; Doak AK; Nedyalkova L; Shoichet BK
    ACS Chem Biol; 2015 Apr; 10(4):978-88. PubMed ID: 25606714
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Promiscuous aggregate-based inhibitors promote enzyme unfolding.
    Coan KE; Maltby DA; Burlingame AL; Shoichet BK
    J Med Chem; 2009 Apr; 52(7):2067-75. PubMed ID: 19281222
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High-throughput assays for promiscuous inhibitors.
    Feng BY; Shelat A; Doman TN; Guy RK; Shoichet BK
    Nat Chem Biol; 2005 Aug; 1(3):146-8. PubMed ID: 16408018
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gini coefficient: a new way to express selectivity of kinase inhibitors against a family of kinases.
    Graczyk PP
    J Med Chem; 2007 Nov; 50(23):5773-9. PubMed ID: 17948979
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selectivity of kinase inhibitor fragments.
    Bamborough P; Brown MJ; Christopher JA; Chung CW; Mellor GW
    J Med Chem; 2011 Jul; 54(14):5131-43. PubMed ID: 21699136
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Kinetic and molecular modeling of nucleoside and nucleotide inhibition of malate dehydrogenase.
    Harris DG; Marx DP; Anderson JM; McCune RW; Zimmerman SS
    Nucleosides Nucleotides Nucleic Acids; 2002; 21(11-12):813-23. PubMed ID: 12537023
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development and experimental validation of a docking strategy for the generation of kinase-targeted libraries.
    Gozalbes R; Simon L; Froloff N; Sartori E; Monteils C; Baudelle R
    J Med Chem; 2008 Jun; 51(11):3124-32. PubMed ID: 18479119
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stability and equilibria of promiscuous aggregates in high protein milieus.
    Coan KE; Shoichet BK
    Mol Biosyst; 2007 Mar; 3(3):208-13. PubMed ID: 17308667
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synergy and antagonism of promiscuous inhibition in multiple-compound mixtures.
    Feng BY; Shoichet BK
    J Med Chem; 2006 Apr; 49(7):2151-4. PubMed ID: 16570910
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interpreting steep dose-response curves in early inhibitor discovery.
    Shoichet BK
    J Med Chem; 2006 Dec; 49(25):7274-7. PubMed ID: 17149857
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A detergent-based assay for the detection of promiscuous inhibitors.
    Feng BY; Shoichet BK
    Nat Protoc; 2006; 1(2):550-3. PubMed ID: 17191086
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of the inhibitor-resistant M69V substitution on the structures and populations of trans-enamine beta-lactamase intermediates.
    Totir MA; Padayatti PS; Helfand MS; Carey MP; Bonomo RA; Carey PR; van den Akker F
    Biochemistry; 2006 Oct; 45(39):11895-904. PubMed ID: 17002290
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Affinity purification of proteins binding to kinase inhibitors immobilized on self-assembling monolayers.
    Bantscheff M; Hobson S; Kuster B
    Methods Mol Biol; 2012; 795():149-60. PubMed ID: 21960221
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nuclear export inhibitors and kinase inhibitors identified using a MAPK-activated protein kinase 2 redistribution screen.
    Almholt DL; Loechel F; Nielsen SJ; Krog-Jensen C; Terry R; Bjørn SP; Pedersen HC; Praestegaard M; Møller S; Heide M; Pagliaro L; Mason AJ; Butcher S; Dahl SW
    Assay Drug Dev Technol; 2004 Feb; 2(1):7-20. PubMed ID: 15090206
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structure-based enhancement of boronic acid-based inhibitors of AmpC beta-lactamase.
    Weston GS; Blázquez J; Baquero F; Shoichet BK
    J Med Chem; 1998 Nov; 41(23):4577-86. PubMed ID: 9804697
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.